propafenone has been researched along with Blood Pressure, Low in 9 studies
Propafenone: An antiarrhythmia agent that is particularly effective in ventricular arrhythmias. It also has weak beta-blocking activity.
propafenone : An aromatic ketone that is 3-(propylamino)propane-1,2-diol in which the hydrogen of the primary hydroxy group is replaced by a 2-(3-phenylpropanoyl)phenyl group. It is a class 1C antiarrhythmic drug with local anesthetic effects, and is used as the hydrochloride salt in the management of supraventricular and ventricular arrhythmias.
| Excerpt | Relevance | Reference |
|---|---|---|
| "A prospective, randomized, double-blind study to compare the efficacy in terminating postoperative atrial fibrillation of the class Ic drug propafenone versus class Ia drug procainamide was conducted." | 9.09 | Comparison of propafenone versus procainamide for the acute treatment of atrial fibrillation after cardiac surgery. ( Geelen, P; O'Hara, GE; Plante, S; Roy, D; Roy, N; Talajic, M; Turgeon, J, 1999) |
| "We present two cases of proarrhythmia after propafenone treatment." | 7.74 | [Proarrhythmic effect of propafenone in patients with atrial fibrillation and atrial flutter]. ( Jastrzebski, M, 2008) |
| "The safety and efficacy of intravenous Propafenone, in the treatment of atrial fibrillation (a." | 7.67 | [Fibrillation and atrial flutter. Immediate control and conversion to sinus rhythm with intravenous propafenone]. ( Bianconi, L; Boccadamo, R; Broglia, R; Pappalardo, A; Pistolese, M, 1987) |
| "A prospective, randomized, double-blind study to compare the efficacy in terminating postoperative atrial fibrillation of the class Ic drug propafenone versus class Ia drug procainamide was conducted." | 5.09 | Comparison of propafenone versus procainamide for the acute treatment of atrial fibrillation after cardiac surgery. ( Geelen, P; O'Hara, GE; Plante, S; Roy, D; Roy, N; Talajic, M; Turgeon, J, 1999) |
| "We present two cases of proarrhythmia after propafenone treatment." | 3.74 | [Proarrhythmic effect of propafenone in patients with atrial fibrillation and atrial flutter]. ( Jastrzebski, M, 2008) |
| "The safety and efficacy of intravenous Propafenone, in the treatment of atrial fibrillation (a." | 3.67 | [Fibrillation and atrial flutter. Immediate control and conversion to sinus rhythm with intravenous propafenone]. ( Bianconi, L; Boccadamo, R; Broglia, R; Pappalardo, A; Pistolese, M, 1987) |
| "Guidelines recommend that initial trial of a "pill-in-the-pocket" (PIP) Class 1C antiarrhythmic drug (AAD) for cardioversion of atrial fibrillation (AF) be performed in a monitored setting because of the potential for adverse reactions." | 1.72 | Safety of Pill-in-the-Pocket Class 1C Antiarrhythmic Drugs for Atrial Fibrillation. ( Arkles, JS; Callans, DJ; Deo, R; Dixit, S; Epstein, AE; Frankel, DS; Guandalini, GS; Hyman, MC; Jarrah, AA; Lin, D; Marchlinski, FE; Markman, TM; Mustin, E; Nazarian, S; Riley, M; Santangeli, P; Schaller, RD; Supple, GE; Tian, Y, 2022) |
| "Propafenone is a sodium-channel blocker, class IC antiarrhythmic drug, frequently used to manage supraventricular dysrhythmias, especially atrial fibrillation." | 1.48 | Failure of Intracardiac Pacing After Fatal Propafenone Overdose: A Case Report. ( Brkljačić, DD; Bulj, N; Čabrilo, V; Kolačević, M; Manola, Š; Zeljković, I, 2018) |
| "Propafenone is a Vaughan Williams class 1c antiarrhythmic medication widely used for treatment of arrhythmias." | 1.46 | Revisiting propafenone toxicity. ( Alsaad, AA; Austin, CO; Kusumoto, F; Ortiz Gonzalez, Y, 2017) |
| "Two patients with recurrences of sustained VT in this group were later successfully treated with propafenone, 900 mg/day; overall, 8 of 9 patients with recurrences of sustained VT were successfully treated with 900 mg/day." | 1.27 | Propafenone for refractory ventricular arrhythmias: correlation with drug plasma levels during long-term treatment. ( Ambrosioni, E; Bracchetti, D; Marchesini, B; Naccarella, F; Palmieri, M, 1984) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (22.22) | 18.7374 |
| 1990's | 1 (11.11) | 18.2507 |
| 2000's | 3 (33.33) | 29.6817 |
| 2010's | 2 (22.22) | 24.3611 |
| 2020's | 1 (11.11) | 2.80 |
| Authors | Studies |
|---|---|
| Markman, TM | 1 |
| Jarrah, AA | 1 |
| Tian, Y | 1 |
| Mustin, E | 1 |
| Guandalini, GS | 1 |
| Lin, D | 1 |
| Epstein, AE | 1 |
| Hyman, MC | 1 |
| Deo, R | 1 |
| Supple, GE | 1 |
| Arkles, JS | 1 |
| Dixit, S | 1 |
| Schaller, RD | 1 |
| Santangeli, P | 1 |
| Nazarian, S | 1 |
| Riley, M | 1 |
| Callans, DJ | 1 |
| Marchlinski, FE | 1 |
| Frankel, DS | 1 |
| Alsaad, AA | 1 |
| Ortiz Gonzalez, Y | 1 |
| Austin, CO | 1 |
| Kusumoto, F | 1 |
| Zeljković, I | 1 |
| Bulj, N | 1 |
| Kolačević, M | 1 |
| Čabrilo, V | 1 |
| Brkljačić, DD | 1 |
| Manola, Š | 1 |
| Tsiperfal, A | 1 |
| Scheibly, K | 1 |
| Matsuda, K | 1 |
| Jastrzebski, M | 1 |
| Unal, S | 1 |
| Bayrakci, B | 1 |
| Yasar, U | 1 |
| Karagoz, T | 1 |
| Naccarella, F | 1 |
| Bracchetti, D | 1 |
| Palmieri, M | 1 |
| Marchesini, B | 1 |
| Ambrosioni, E | 1 |
| Geelen, P | 1 |
| O'Hara, GE | 1 |
| Roy, N | 1 |
| Talajic, M | 1 |
| Roy, D | 1 |
| Plante, S | 1 |
| Turgeon, J | 1 |
| Bianconi, L | 1 |
| Boccadamo, R | 1 |
| Pappalardo, A | 1 |
| Broglia, R | 1 |
| Pistolese, M | 1 |
1 trial available for propafenone and Blood Pressure, Low
| Article | Year |
|---|---|
Comparison of propafenone versus procainamide for the acute treatment of atrial fibrillation after cardiac surgery.
Topics: Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Cardiac Surgical Procedures; Coronary Artery Bypa | 1999 |
8 other studies available for propafenone and Blood Pressure, Low
| Article | Year |
|---|---|
Safety of Pill-in-the-Pocket Class 1C Antiarrhythmic Drugs for Atrial Fibrillation.
Topics: Adult; Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Bradycardia; Female; Flecainide; Humans; H | 2022 |
Revisiting propafenone toxicity.
Topics: Aged; Anti-Arrhythmia Agents; Bradycardia; Humans; Hypotension; Male; Propafenone | 2017 |
Failure of Intracardiac Pacing After Fatal Propafenone Overdose: A Case Report.
Topics: Aged; Autopsy; Cardiac Catheters; Cardiac Pacing, Artificial; Consciousness Disorders; Drug Overdose | 2018 |
Can QRS Widening be a result of propafenone overdose?
Topics: Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrial Fibrillation; Consciousness Disorders; Drug Ove | 2008 |
[Proarrhythmic effect of propafenone in patients with atrial fibrillation and atrial flutter].
Topics: Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrial Fibrillation; Atrial Flutter; Bundle-Branch Blo | 2008 |
Successful treatment of propafenone, digoxin and warfarin overdosage with plasma exchange therapy and rifampicin.
Topics: Adolescent; Anti-Arrhythmia Agents; Anticoagulants; Bradycardia; Cytochrome P-450 Enzyme System; Dig | 2007 |
Propafenone for refractory ventricular arrhythmias: correlation with drug plasma levels during long-term treatment.
Topics: Adult; Aged; Anti-Arrhythmia Agents; Chromatography, High Pressure Liquid; Dizziness; Female; Humans | 1984 |
[Fibrillation and atrial flutter. Immediate control and conversion to sinus rhythm with intravenous propafenone].
Topics: Adult; Aged; Aged, 80 and over; Atrial Fibrillation; Atrial Flutter; Female; Humans; Hypotension; In | 1987 |